Glycouniverse GmbH & Co. Kommanditgesellschaft Auf Aktien

Glycouniverse GmbH & Co. Kommanditgesellschaft Auf Aktien is an SME in Potsdam, Germany that has taken part in 5 EU-funded projects since 2015, receiving €1.3M in EU funding.

EU funding received€1.3M
EU projects5
As coordinator0
Running now2
First EU project2015
Latest project2027
CountryGermany
EU registration (PIC)948392281
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Glycouniverse GmbH & Co. Kommanditgesellschaft Auf Aktien's own share of each project, not the project's full budget.

  • Horizon 2020€751k · 3 projects
  • Horizon Europe€551k · 2 projects

Projects

5 EU-funded projects, newest first. Each links to the official record.

  • GlycoAxisPartner

    Training the next generation of scientists on cell surface Glycans from Gram-negative gut microbiota as molecular keys to decOde the gut-immune-brain Axis

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

    €290ktheir share
  • ACINETWORKPartner

    A training network for the design of synthetic carbohydrate-based vaccines in the fight against multi-drug resistant nosocomial pathogen Acinetobacter baumannii

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €261ktheir share
  • GLYTUNESPartner

    A multidisciplinary training network for the bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €253ktheir share
  • GLYCOVAXPartner

    A training network for the rational design of the next generation of well-defined glycoconjugate vaccines

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €249ktheir share
  • IMMUNOSHAPEPartner

    Development of Selective Carbohydrate Immunomodulators Targeting C-type Lectin Receptors on Antigen Presenting Cells

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

    €249ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • allergology
  • antibiotic resistance
  • antibiotics
  • autoimmune diseases
  • biochemistry
  • biophysics
  • carbohydrates
  • immunology
  • immunotherapy
  • medicinal chemistry
  • microbiology
  • nanomedicine
  • nanotechnology
  • neurobiology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime